German Transportation Stock News

On 20 January 2026, Avanos Medical and Siemens Healthineers announced a co-marketing agreement in the U.S. to combine imaging and radiofrequency ablation technologies for outpatient and interventional pain care across ambulatory surgery centers, hospitals, and pain practices. This collaboration aims to build an integrated ecosystem that could streamline workflow and improve consistency in pain procedures, highlighting Siemens Healthineers’ push to deepen its role in outpatient care...

What adidas (XTRA:ADS) investors can see in the recent performance snapshot With no single headline event driving adidas (XTRA:ADS) today, investors are instead working with a snapshot that combines recent share performance, profitability figures and a set of mixed return profiles over different timeframes. See our latest analysis for adidas. At a share price of $153.0, adidas is coming off a 1-day share price return of 0.96% after a weaker run that includes a 19.13% decline over 90 days and...

Deutsche Telekom (XTRA:DTE) has moved to tighten trust in voice calls, partnering with Hiya and First Orion to roll out network-level branded calling across Germany, giving investors fresh context around its core telecom services. See our latest analysis for Deutsche Telekom. The recent client announcements around branded calling come at a time when Deutsche Telekom’s share price has eased, with the latest close at €26.87 and a 90 day share price return showing a decline of 10.52%. The 5 year...

Sartorius (XTRA:SRT3) is back in focus after expanding its bio circular product range, with additional German and Tunisian facilities now ISCC Plus certified to use renewable raw materials in several bioprocessing lines. See our latest analysis for Sartorius. That push into certified bio circular products comes as Sartorius trades at €254.4, with a 30 day share price return of 5.96% and a 1 year total shareholder return of 5.69%, set against a 3 year total shareholder return decline of 36.31%...

As the European markets show resilience with the STOXX Europe 600 Index rising by 0.77%, investors are keenly observing growth opportunities amid mixed performances across major indices. In this environment, companies with strong insider ownership often attract attention, as insiders' stakes can signal confidence in long-term prospects and align interests with shareholders.

The European market has shown resilience, with the STOXX Europe 600 Index ending higher, buoyed by robust economic data and mixed earnings results across major stock indexes. Amid this backdrop, the concept of penny stocks remains pertinent as these smaller or newer companies can offer unique growth opportunities. While the term might seem outdated, penny stocks continue to capture investor interest due to their potential for significant returns when backed by strong financials and fundamentals.

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Long term investing works well, but it doesn't always work for each individual stock. We really hate to see fellow...

With a price-to-earnings (or "P/E") ratio of 3.7x Francotyp-Postalia Holding AG ( HMSE:FPH ) may be sending very...

Most readers would already be aware that Jenoptik's (ETR:JEN) stock increased significantly by 16% over the past month...

RTL Group S.A.'s ( ETR:RRTL ) price-to-earnings (or "P/E") ratio of 22.9x might make it look like a sell right now...

Key Insights Nemetschek's estimated fair value is €117 based on 2 Stage Free Cash Flow to Equity Current share price of...

Stabilus SE ( ETR:STM ) has announced that on 9th of February, it will be paying a dividend of€0.35, which a reduction...

Carl Zeiss Meditec (XTRA:AFX) is set to engage investors at the 25th German Corporate Conference in Frankfurt, where its CFO and Investor Relations head plan to discuss the business and address market questions. See our latest analysis for Carl Zeiss Meditec. At a share price of €39.44, Carl Zeiss Meditec has seen pressure on momentum, with a 90 day share price return of a 17.35% decline and a 1 year total shareholder return of a 17.28% loss, so investors will be watching the conference for...

Sales update puts Redcare Pharmacy in focus Redcare Pharmacy (XTRA:RDC) is back on investors’ radar after reporting fourth quarter 2025 group sales of €794 million, compared with €675 million a year earlier, alongside full year sales of €2.9b versus €2.4b in 2024. See our latest analysis for Redcare Pharmacy. Despite the strong sales update, Redcare Pharmacy’s share price has had a weak run, with a 90 day share price return of 24.46% decline and a 1 year total shareholder return of 45.89%...

While CTS Eventim AG & Co. KGaA ( ETR:EVD ) might not have the largest market cap around , it saw significant share...

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

BRAIN Biotech AG ( ETR:BNN ) is possibly approaching a major achievement in its business, so we would like to shine...

With a price-to-earnings (or "P/E") ratio of 37.2x Knorr-Bremse AG ( ETR:KBX ) may be sending very bearish signals at...

Investing in stocks inevitably means buying into some companies that perform poorly. Long term PNE AG ( ETR:PNE3...

If you are wondering whether Mercedes-Benz Group is attractively priced right now, this article walks through what the current share price really reflects. The stock closed at €58.82, with returns of a 2.6% decline over 7 days, a 1.7% decline over 30 days, a 5.0% decline year to date, a 16.0% return over 1 year, 13.2% over 3 years and 65.6% over 5 years. This gives you a mix of shorter term weakness and longer term gains to think about. Recent coverage around Mercedes-Benz Group has focused...

Recent coverage indicates that Bechtle AG’s AI-related services are helping drive higher-margin projects and growing recurring managed-service bookings across its European customer base. This shift toward AI-enabled, service-based work highlights how Bechtle may be reshaping its revenue mix toward more resilient, contract-driven income streams. Next, we’ll examine how rising AI-driven, higher-margin managed-service demand could influence Bechtle’s existing investment narrative and risk...

Redcare Pharmacy NV recently reported its fourth-quarter 2025 sales of €794 million, up from €675 million a year earlier, with full-year 2025 sales rising to €2.90 billion from €2.40 billion in 2024. This sales expansion underscores how Redcare Pharmacy is scaling its online pharmacy operations across Europe, reinforcing its position in the digital healthcare market. We’ll now examine how this step-up in annual sales reshapes Redcare Pharmacy’s investment narrative, especially around revenue...